share_log

Oppenheimer Reiterates Outperform on Perspective Therapeutics, Raises Price Target to $1.5

Moomoo 24/7 ·  Apr 1 09:27

Oppenheimer analyst Jeff Jones reiterates Perspective Therapeutics (AMEX:CATX) with a Outperform and raises the price target from $1.2 to $1.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment